Actively Recruiting
Screening of Malignant Hyperthermia Susceptible Individuals
Led by Peking University Third Hospital · Updated on 2022-06-02
50
Participants Needed
1
Research Sites
988 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study intends to target patients who underwent surgery under general anesthesia during the study period and developed malignant hyperthermia during or after surgery. Therefore, the total sample size was estimated to be about 50 people based on the past incidence of this rare disease. Every year, about 20 patients and their families who developed malignant hyperthermia during or after surgery will participate in this nationwide study (estimated by the current incidence of malignant hyperthermia), and about 1-5 patients will be admitted to Peking University Third Hospital participate in this research. Relevant specimens were collected from malignant hyperthermia (MH) patients and their family members for genetic analysis to determine the mutation of MH-related pathogenic gene loci.
CONDITIONS
Official Title
Screening of Malignant Hyperthermia Susceptible Individuals
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing surgery under general anesthesia during the study period who developed malignant hyperthermia during or after surgery.
You will not qualify if you...
- Malignant hyperthermia was ruled out by later treatment and diagnosis.
- The patient or family member refuses to be recruited.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100191
Actively Recruiting
Research Team
Y
Yinyin Qu, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here